PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,012.00
Bid: 1,012.00
Ask: 1,016.00
Change: -3.00 (-0.30%)
Spread: 4.00 (0.395%)
Open: 1,018.00
High: 1,018.00
Low: 1,005.00
Prev. Close: 1,015.00
DNLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Targets for long term share incentive awards

10 May 2021 07:00

RNS Number : 9797X
Dunelm Group plc
10 May 2021
 

DUNELM GROUP plc

(the "Company")

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITY AND CONNECTED PERSONS

10 May 2021

 

Targets for long term share incentive awards granted to Nick Wilkinson and Laura Carr in 2020

 

As previously announced, on 20 November 2020, the Company granted a conditional nil-cost option under the Long-term Incentive Plan (the FY21 -23 Award) to Nick Wilkinson and Laura Carr as set out in the table below.

  Name

Role

Number of conditional nil cost options awarded under Long-Term Incentive Plan

Nick Wilkinson

CEO

94,846

Laura Carr

CFO

58,166

 

The above options may be exercised on or after 20 November 2023, subject to the satisfaction of performance conditions over the three financial years commencing on 28 June 2020.

 

As disclosed in the FY20 Directors' Remuneration Report, the Committee felt it was unlikely that it would be able to set meaningful but stretching three-year targets for the FY21-23 Award at the grant date, given the significant Covid related uncertainty in the wider economic environment. In a departure from its normal practice, and in line with the Investment Association's guidance issued in May 2020, the Committee agreed to set the performance conditions applicable to the award by May 2021.

The Committee has taken into account the Group's business plan, as well as the outlook for the sector and general macroeconomic conditions, and the range of analysts' consensus forecasts for FY23. Following careful consideration, the Committee has set the performance condition as set out below, with the number stated being the figure for fully diluted earnings per share (EPS) as set out in the financial statements of the Company for the year ending June 2023:

FY21-23 LTIP Award - Performance targets

 

Fully diluted EPS of the Company for FY23

Less than 60.0p

60.0p

65.0p

72.5p

80.0p or more

Compound annual growth rate

 

11.8%

14.8%

19.1%

23.0%

Percentage of the FY21-23 Award vesting*

Nil

10%

50%

75%

100%

 

*Performance between each of these percentage thresholds will be calculated on a straight line basis

 

The proposed performance targets represent significant growth in total profitability compared to the pre-Covid-19 FY19 financial performance. The Remuneration Committee reserves the right to adjust the targets in the event of unexpected changes in tax rates.

In line with its 2020 Remuneration Policy, the Remuneration Committee can apply malus or clawback to the award, and has discretion to vary formulaic outturns where this does not reflect underlying performance or is inappropriate in the context of unexpected or unforeseen circumstances.

 

Further, in accordance with the shareholding requirements set out in the 2020 Remuneration Policy, on exercise Mr Wilkinson and Mrs Carr have each committed to retain all of the shares vesting (after sale to cover their tax and national insurance liability on exercise), until 20 November 2025, and at least two thirds of these for the duration of employment. In addition, shareholding requirements apply for the duration of employment and for two years from termination of employment, as set out in the 2020 Remuneration Policy.

 

Name of authorised Company official responsible for making this notification:

 

Dawn Durrant, Company Secretary

For further information please contact:

Dunelm Group plc

Investorrelations@dunelm.com

Dawn Durrant, Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHARMATMTMMBLB
Date   Source Headline
12th Jul 20197:00 amRNSDirector/PDMR Shareholding
10th Jul 20197:00 amRNSDirectorate Change
10th Jul 20197:00 amRNSFourth Quarter Trading Update
28th Jun 20197:00 amRNSTotal Voting Rights
20th Jun 20197:00 amRNSTrading Update
31st May 20197:00 amRNSTotal Voting Rights
10th Apr 20197:00 amRNSThird Quarter Trading Update
9th Apr 20197:00 amRNSBlock listing Interim Review
9th Apr 20197:00 amRNSBlock listing Interim Review
9th Apr 20197:00 amRNSBlock listing Interim Review
9th Apr 20197:00 amRNSBlock listing Interim Review
29th Mar 20197:00 amRNSTotal Voting Rights
13th Feb 20197:00 amRNSInterim Results
7th Jan 20197:00 amRNSSecond Quarter Trading Update
7th Dec 20187:00 amRNSGift of shares and Director/PDMR holding
7th Dec 20187:00 amRNSHolding(s) in Company
7th Dec 20187:00 amRNSHolding(s) in Company
7th Dec 20187:00 amRNSHolding(s) in Company
3rd Dec 20187:01 amRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSDirector/PDMR Shareholding
29th Nov 201812:40 pmRNSResult of AGM
29th Nov 20187:00 amRNSConfirmation of Board Changes
16th Nov 20188:14 amRNSSharesave option granted to Nick Wilkinson
30th Oct 20187:00 amRNSTotal Voting Rights
18th Oct 20187:00 amRNSDirector/PDMR Shareholding
15th Oct 20187:00 amRNSDirector/PDMR Shareholding
11th Oct 20187:00 amRNSFirst Quarter Trading Update
9th Oct 20187:00 amRNSAnnual Financial Report
5th Oct 20187:00 amRNSBlock listing Interim Review
5th Oct 20187:00 amRNSBlock listing Interim Review
5th Oct 20187:00 amRNSBlock listing Interim Review
5th Oct 20187:00 amRNSBlock listing Interim Review
12th Sep 20187:00 amRNSFinal Results
29th Aug 20187:00 amRNSBoard Changes
23rd Aug 201810:49 amRNSDirector Declaration
2nd Aug 20189:41 amRNSHolding(s) in Company
23rd Jul 20187:00 amRNSDirector/PDMR Shareholding
13th Jul 201810:51 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSYear-end Trading Update
29th May 20187:00 amRNSDirector/PDMR Shareholding
25th May 201811:56 amRNSTrading Update
18th May 20187:00 amRNSAppointment of Chief Financial Officer
12th Apr 20187:00 amRNSThird Quarter Trading Update
10th Apr 20187:00 amRNSBlock listing Interim Review
10th Apr 20187:00 amRNSBlock listing Interim Review
10th Apr 20187:00 amRNSBlock listing Interim Review
10th Apr 20187:00 amRNSBlock listing Interim Review
3rd Apr 20187:00 amRNSConfirmation of appointment of Rachel Osborne
23rd Mar 20188:28 amRNSTR-1
23rd Mar 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.